Mineralys Therapeutics, Inc. Common Stock (MLYS) News

Latest headlines that mention MLYS, newest first · each headline opens the original publisher

MLYS quote

Last price: $16.07
Day change: +4.79%
Next earnings: —

Quote & chart Expected move Insider trading IV rank history

MLYS headlines

last 30 days

Investing.com 2h ago

Why is Mineralys Therapeutics stock climbing today?

General T3MLYS

Investing.com 2h ago

Mineralys stock gains after drug shows sustained blood pressure cuts

General T3MLYS

Seeking Alpha News 4d ago

Mineralys: Fairly Valued Near $17 As Baxfendy Launch Validates Slow ASI Ramp (Upgrade)

General T2MLYS

Seeking Alpha 4d ago

Mineralys outlines December 22 PDUFA timeline while funding lorundrostat launch into 2028

General T2MLYS

Seeking Alpha News 4d ago

Mineralys Therapeutics, Inc. (MLYS) Q3 2026 Earnings Call Transcript

Earnings T2MLYS

Seeking Alpha 4d ago

Mineralys Therapeutics GAAP EPS of -$0.64 misses by $0.09

Earnings T2MLYS

Investing.com 12d ago

Mineralys reports positive phase 2 CKD trial results

General T3MLYS

Investing.com 20d ago

Mineralys appoints two directors ahead of drug launch

General T3MLYS

Investing.com 27d ago

Mineralys Therapeutics CEO Jon Congleton sells $1.9m MLYS stock

General T3MLYS

Investing.com 28d ago

H.C. Wainwright reiterates Mineralys stock rating on new data

General T3MLYS

MLYS news alerts

Get an alert by email or push when a new headline mentions MLYS.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.